CorMedix Inc’s recent filing unveils that its EVP, Chief Commercial Officer Mistry Erin acquired Company’s shares for reported $14985.0 on Oct 31 ’24. In the deal valued at $9.99 per share,1,500 shares were bought. As a result of this transaction, Mistry Erin now holds 52,011 shares worth roughly $0.44 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hurlburt Elizabeth sold 140,027 shares, generating $1,565,670 in total proceeds. Upon selling the shares at $11.18, the EVP now owns 45,397 shares.
Before that, Hurlburt Elizabeth bought 140,027 shares. CorMedix Inc shares valued at $1,556,416 were divested by the Officer at a price of $11.12 per share.
Rodman & Renshaw initiated its CorMedix Inc [CRMD] rating to a Buy in a research note published on August 26, 2024; the price target was $13. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in early August with a ‘”an Outperform”‘ rating. Needham began covering CRMD with “Buy” recommendation on February 17, 2021. JMP Securities started covering the stock on September 29, 2020. It rated CRMD as “a Mkt outperform”.
Price Performance Review of CRMD
On Monday, CorMedix Inc [NASDAQ:CRMD] saw its stock fall -1.75% to $8.42. Over the last five days, the stock has gained 1.32%. CorMedix Inc shares have risen nearly 123.94% since the year began. Nevertheless, the stocks have risen 133.24% over the past one year. While a 52-week high of $13.85 was reached on 10/29/24, a 52-week low of $2.89 was recorded on 02/08/24. SMA at 50 days reached $10.32, while 200 days put it at $6.59.
Levels Of Support And Resistance For CRMD Stock
The 24-hour chart illustrates a support level at 8.21, which if violated will result in even more drops to 8.00. On the upside, there is a resistance level at 8.59. A further resistance level may holdings at 8.76. The Relative Strength Index (RSI) on the 14-day chart is 38.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.73%. Stochastics %K at 30.72% indicates the stock is a holding.
How much short interest is there in CorMedix Inc?
A steep rise in short interest was recorded in CorMedix Inc stocks on 2024-11-29, growing by 0.61 million shares to a total of 6.89 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 6.28 million shares. There was a rise of 8.81%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 21, 2020 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
